By converting global risk signals into actionable growth edges, Indian businesses can not only safeguard their operations but also position...

Despite facing geopolitical instability and weather-related challenges, India's economy is expected to grow robustly at 6.9% in FY27. This ...

Hyderabad's economic future took center stage at the inaugural Hyderabad Economic Forum 2026, themed 'One City. One Vision. Infinite Possib...

Despite challenges like fluctuating gold prices and evolving consumer tastes, experts highlight opportunities in design-led, innovative pra...

Cummins India is aggressively investing in electric, fuel blending, and hydrogen technologies to secure growth beyond 2030 and counter risi...

Indian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...

HDFC Life Insurance reported a robust 12% year-on-year growth in total premium for FY26, with its retail protection business soaring by 43%...

Tata Motors anticipates short-term headwinds for commercial vehicle demand due to West Asia war-induced diesel price hikes. However, MD & C...

Market expert Dharmesh Kant sees commodity corrections as buying opportunities, with the broader cycle intact due to global demand and Indi...

Bharti Airtel's credit rating has been boosted to 'BBB+' by S&P Global Ratings, reflecting robust earnings growth anticipated in India and ...

ITC Chairman Sanjiv Puri revealed plans for a Rs 20,000 crore investment over the medium term, including hotel expansion. He highlighted st...

JP Morgan has initiated coverage of India’s capital markets sector with a bullish outlook, citing resilient SIP inflows and rising retail f...

Nikhil Kamath, Zerodha co-founder, sees significant investment potential in the energy transition, citing the U.S.-Iran conflict's emphasis...

India needs sustained 7-8% economic growth to become 'Viksit Bharat' by 2047, driven by private investment and exports. Structural reforms ...

Tata Motors Passenger Vehicles is projecting a significant revenue surge, aiming to surpass Rs 6 lakh crore by fiscal year 2031 with a 10% ...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Brokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...